Results 111 to 120 of about 13,942 (180)

Correction to "Beyond Infections: A Case Report on the Identification of Neuroleptic Malignant Syndrome (NMS) in a Complex Clinical Context". [PDF]

Clin Case Rep
europepmc   +1 more source

Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss. [PDF]

Ann Clin Transl Neurol
Englund S, Reutfors J, Frisell T, Piehl F.   +3 more
europepmc   +1 more source

Enhancing amantadine delivery through PLGA micelles: a novel approach using oleic acid and Pluronic F68 for sustained release and reduced toxicity. [PDF]

RSC Adv
Adwibi IA, Chakraborty S, Ibrahim B, Ali-Boucetta H, Valsami-Jones E.   +4 more
europepmc   +1 more source

The Effect of Dopaminergic Therapies in Parkinson's Disease on Non-Motor Symptoms. [PDF]

Int J Mol Sci
Jampolska M, Kaczyńska K.
europepmc   +1 more source

Prevalence and clinical characteristics of impulse control disorder in Southern Brazilian Parkinson's disease patients. [PDF]

Arq Neuropsiquiatr
Carvalho Neto EG, Soares NM, Pereira GM, Dalla Corte BM, Dutra ACL, Artigas NR, Almeida RMM, Krimberg JS, Monticelli BE, Schuh AFS, Rieder CRM.   +10 more
europepmc   +1 more source

Commentary: Real-world effectiveness and safety of xanomeline and trospium for treatment-resistant schizophrenia in a state hospital system. [PDF]

Front Psychiatry
Price MZ, Price RL.
europepmc   +1 more source

Demise of the Milwaukee Protocol for Rabies. [PDF]

Clin Infect Dis
Jackson AC.
europepmc   +1 more source

Supramolecular purification of mono-adamantane mixtures <i>via</i> stabilized three-shell Matryoshka assemblies. [PDF]

Chem Sci
Sabrià C, Pèlachs T, Imaz I, Maspoch D, Feixas F, Ribas X.   +5 more
europepmc   +1 more source

Efficacy and Safety of Twelve Anti-Dyskinetic Drugs in Parkinson's Disease: A Bayesian Network Meta-Analysis of Randomized Controlled Trials. [PDF]

Eur J Neurol
Chen FF, Wen SY, Chen XT, Zhang Q, Tao P, Meng C, Huang J, Chen W, Zhou CQ.   +8 more
europepmc   +1 more source